Cericlamine

CAS No. 112922-55-1

Cericlamine( —— )

Catalog No. M36145 CAS No. 112922-55-1

Cericlamine is a selective 5-hydroxytryptamine (5-HT) reuptake blocker with antidepressant activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 198 Get Quote
5MG 304 Get Quote
10MG 456 Get Quote
25MG 723 Get Quote
50MG 994 Get Quote
100MG 1332 Get Quote
500MG 2664 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Cericlamine
  • Note
    Research use only, not for human use.
  • Brief Description
    Cericlamine is a selective 5-hydroxytryptamine (5-HT) reuptake blocker with antidepressant activity.
  • Description
    Cericlamine is a selective 5-hydroxytryptamine (5-HT) reuptake blocker with antidepressant activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    5-HT Receptor
  • Recptor
    5-HT Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    112922-55-1
  • Formula Weight
    262.18
  • Molecular Formula
    C12H17Cl2NO
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(CC1=CC(Cl)=C(Cl)C=C1)(N(C)C)(CO)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • AL 34662

    AL 34662 is a selective and potent 5-HT2A receptor agonist with IC50s of 0.77 nM and 1.5 nM for rat and human 5-HT2 receptors, respectively.AL 34662 is also a low affinity α-1D adrenergic agonist, with an EC50 of 0.4 μM.AL 34662 can be used to lower intraocular pressure.

  • Liafensine

    Liafensine(BMS-820836) is a novel and selective triple monoamine reuptake inhibitor with inhibitory effects on the reuptake of serotonin, norepinephrine, and dopamine for the study of major depressive disorder and central nervous system disorders.

  • Velusetrag hydrochlo...

    Velusetrag (TD-5108) is a potent, selective and oral 5-HT4 receptor agonist with pKi of 7.7, shows >500-fold selectivity over other 5-HT receptors.